Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity
- PMID: 29449068
- DOI: 10.1016/j.cyto.2018.02.012
Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity
Abstract
Chemokines are mostly known for their chemotactic properties, and less for their ability to direct the biological function of target cells, including T cells. The current review focuses on a key chemokine named CXCL10 and its role in directing the migratory propertied and biological function of CD4+ and CD8+ T cells in the context of cancer and inflammatory autoimmunity. CXCR3 is a chemokine receptor that is abundant on CD4+ T cells, CD8+ T cells and NK cells. It has three known ligands: CXCL9, CXCL10 and CXCL11. Different studies, including those coming form our laboratory, indicated that aside of attracting CD8+ and CD4+ effector T cells to tumor sites and sites of inflammation CXCL10 directs the polarization and potentiates the biological function of these cells. This makes CXCL10 a "key driver chemokine" and a valid target for therapy of autoimmune diseases such as Inflammatory Bowl's Disease, Multiple Sclerosis, Rheumatoid arthritis and others. As for cancer this motivated different groups, including our group to develop CXCL10 based therapies for cancer due to its ability to enhance T-dependent anti cancer immunity. The current review summarizes these findings and their potential translational implication.
Keywords: Autoimmunity; CXCL10; CXCR3; Cancer; Chemokines.
Copyright © 2018 Elsevier Ltd. All rights reserved.
Similar articles
-
CXCR3 Ligands in Cancer and Autoimmunity, Chemoattraction of Effector T Cells, and Beyond.Front Immunol. 2020 May 29;11:976. doi: 10.3389/fimmu.2020.00976. eCollection 2020. Front Immunol. 2020. PMID: 32547545 Free PMC article. Review.
-
Wrinkle in the plan: miR-34a-5p impacts chemokine signaling by modulating CXCL10/CXCL11/CXCR3-axis in CD4+, CD8+ T cells, and M1 macrophages.J Immunother Cancer. 2020 Nov;8(2):e001617. doi: 10.1136/jitc-2020-001617. J Immunother Cancer. 2020. PMID: 33229509 Free PMC article.
-
The CXC Chemokine Receptor 3 Inhibits Autoimmune Cholangitis via CD8+ T Cells but Promotes Colitis via CD4+ T Cells.Front Immunol. 2018 May 17;9:1090. doi: 10.3389/fimmu.2018.01090. eCollection 2018. Front Immunol. 2018. PMID: 29868034 Free PMC article.
-
The Role of Chemokines in Shaping the Balance Between CD4(+) T Cell Subsets and Its Therapeutic Implications in Autoimmune and Cancer Diseases.Front Immunol. 2015 Nov 30;6:609. doi: 10.3389/fimmu.2015.00609. eCollection 2015. Front Immunol. 2015. PMID: 26648938 Free PMC article. Review.
-
CXCL10/CXCR3-Dependent Mobilization of Herpes Simplex Virus-Specific CD8+ TEM and CD8+ TRM Cells within Infected Tissues Allows Efficient Protection against Recurrent Herpesvirus Infection and Disease.J Virol. 2017 Jun 26;91(14):e00278-17. doi: 10.1128/JVI.00278-17. Print 2017 Jul 15. J Virol. 2017. PMID: 28468883 Free PMC article.
Cited by
-
RNA sequencing reveals molecular mechanisms of endometriosis lesion development in mice.Dis Model Mech. 2024 Oct 1;17(10):dmm050566. doi: 10.1242/dmm.050566. Epub 2024 Oct 23. Dis Model Mech. 2024. PMID: 39385609 Free PMC article.
-
The Major Role of T Regulatory Cells in the Efficiency of Vaccination in General and Immunocompromised Populations: A Review.Vaccines (Basel). 2024 Aug 30;12(9):992. doi: 10.3390/vaccines12090992. Vaccines (Basel). 2024. PMID: 39340024 Free PMC article. Review.
-
Molecular Characterizations of FAM13A and Its Functional Role in Inhibiting the Differentiation of Goat Intramuscular Adipocytes through RIG-I Receptor Signaling Pathway.Genes (Basel). 2024 Aug 30;15(9):1143. doi: 10.3390/genes15091143. Genes (Basel). 2024. PMID: 39336734 Free PMC article.
-
The COMPASS complex maintains the metastatic capacity imparted by a subpopulation of cells in UPS.iScience. 2024 Jun 5;27(7):110187. doi: 10.1016/j.isci.2024.110187. eCollection 2024 Jul 19. iScience. 2024. PMID: 38989451 Free PMC article.
-
Effects of temporal IFNγ exposure on macrophage phenotype and secretory profile: exploring GMP-Compliant production of a novel subtype of regulatory macrophages (MregIFNγ0) for potential cell therapeutic applications.J Transl Med. 2024 Jun 4;22(1):534. doi: 10.1186/s12967-024-05336-y. J Transl Med. 2024. PMID: 38835045 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials